Target intelligence / Profile preview

Bilirubin and Bile Acids

Molecular classification
Metabolites, Endogenous ligands, Biomarkers
01

Overview

Bilirubin and bile acids are essential endogenous metabolites primarily managed by the hepatobiliary system. Bilirubin is a yellow tetrapyrrole pigment produced from the breakdown of heme, while bile acids are steroid-based detergents synthesized from cholesterol in the liver (PubChem CID 5280352). Both substances play critical roles in physiology: bile acids facilitate the emulsification and absorption of dietary fats and vitamins, while bilirubin acts as a potent antioxidant at physiological levels. In clinical medicine, they are primarily utilized as diagnostic biomarkers; elevated levels in the blood (hyperbilirubinemia and elevated serum bile acids) are hallmark indicators of liver dysfunction, biliary obstruction, or hemolytic disorders (StatPearls: Jaundice). Although they are not therapeutic targets in the classical sense, the proteins that regulate their transport (such as OATPs, NTCP, and BSEP) and signaling (such as FXR and TGR5) are major targets for treating cholestatic liver diseases and metabolic conditions (UniProt Q96RI1, Q8TDU6). Drugs like obeticholic acid and ursodeoxycholic acid are used to modulate these pathways to prevent hepatotoxicity and improve bile flow. Additionally, bilirubin metabolism is a key consideration in drug-drug interactions, as many pharmaceuticals compete for the same hepatic transporters and enzymes (Frontiers in Pharmacology, 2018).

Other names
Bile saltsHematoidinCholic acidsBilirubinoidsBile pigments
02

Mechanism of action

FXR agonism, TGR5 agonism, ASBT inhibition, UGT1A1 induction, and bile acid sequestration.

03

Biological functions

Lipid digestionHeme degradationSignalingWaste excretionAntioxidant activity
04

Disease associations

CholestasisJaundiceLiver cirrhosisGallstonesHyperbilirubinemiaMetabolic syndrome
05

Safety considerations

KernicterusPruritusHepatotoxicityDrug-induced liver injury (DILI)Malabsorption of fat-soluble vitamins
06

Interacting drugs

Ursodeoxycholic acid

6 more in the full profile.

07

Biomarkers

Total bilirubinDirect bilirubinSerum total bile acids (TBA)Conjugated bilirubin

Beyond the preview

Go deeper on Bilirubin and Bile Acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bilirubin and Bile Acids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call